These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3950034)

  • 1. Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?
    Panucci A; Fabris C; Del Favero G; Basso D; Di Mario F; Marchioro L; Piccoli A; Lise M; Burlina A; Naccarato R
    J Clin Pathol; 1986 Jan; 39(1):75-7. PubMed ID: 3950034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis].
    Basso D; Fabris C; Del Favero G; Panucci A; Piccoli A; Plebani M; Pedrazzoli S; Baccaglini U; Lise M; Burlina A
    Minerva Med; 1986 Apr; 77(16):613-6. PubMed ID: 3458035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis?
    Basso D; Fabris C; Del Favero G; Panucci A; Plebani M; Angonese C; Leandro G; Dodi G; Burlina A; Naccarato R
    Oncology; 1988; 45(1):24-9. PubMed ID: 3422390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEA and ferritin in chronic pancreatic disease: a comparative evaluation.
    Fabris C; Farini R; Piccoli A; Del Favero G; Panucci A; Plebani M; Pedrazzoli S; Nitti D; Naccarato R
    Hepatogastroenterology; 1985 Jun; 32(3):146-8. PubMed ID: 4018709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
    Basso D; Fabris C; Panucci A; Del Favero G; Angonese C; Plebani M; Petrin P; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S95-100. PubMed ID: 3145303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.
    Fabris C; Del Favero G; Basso D; Piccoli A; Meggiato T; Angonese C; Plebani M; Leandro G; Burlina A; Naccarato R
    Am J Gastroenterol; 1988 May; 83(5):549-53. PubMed ID: 3163228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
    Panucci A; Fabris C; Del Favero G; Basso D; Marchioro L; Piccoli A; Burlina A; Naccarato R
    Br J Cancer; 1985 Nov; 52(5):801-3. PubMed ID: 4063154
    [No Abstract]   [Full Text] [Related]  

  • 11. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases.
    Piantino P; Andriulli A; Gindro T; Pecchio F; Masoero G; Cavallini G; Naccarato R; Dobrilla G
    Am J Gastroenterol; 1986 Jun; 81(6):436-9. PubMed ID: 3458359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer.
    Fabris C; Basso D; Meggiato T; Del Favero G; Piccoli A; Fogar P; Panozzo MP; Faggian D; Naccarato R
    Int J Pancreatol; 1990 Jan; 6(1):i-ii. PubMed ID: 2230355
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis.
    Sharma MP; Gregg JA; Loewenstein MS; McCabe RP; Zamcheck N
    Cancer; 1976 Dec; 38(6):2457-61. PubMed ID: 1000475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.
    Farini R; Fabris C; Bonvicini P; Piccoli A; del Favero G; Venturini R; Panucci A; Naccarato R
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):429-32. PubMed ID: 3859414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Br J Cancer; 1993 Apr; 67(4):852-5. PubMed ID: 8471445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
    Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R
    Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis.
    Del Favero G; Fabris C; Plebani M; Panucci A; Piccoli A; Perobelli L; Pedrazzoli S; Baccaglini U; Burlina A; Naccarato R
    Cancer; 1986 Apr; 57(8):1576-9. PubMed ID: 3456255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9.
    Slesak B; Harlozinska-Szmyrka A; Knast W; Sedlaczek P; van Dalen A; Einarsson R
    Cancer; 2000 Jul; 89(1):83-8. PubMed ID: 10897004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.